Literature DB >> 26091271

Academic drug discovery within the United Kingdom: a reassessment.

Emma Shanks1, Robin Ketteler2, Daniel Ebner3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26091271     DOI： 10.1038/nrd4661

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  6 in total

1.  UK academic drug discovery.

Authors:  Cathy Tralau-Stewart; Caroline M R Low; Nicola Marlin
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

2.  US academic drug discovery.

Authors:  Stephen Frye; Marina Crosby; Teresa Edwards; Rudolph Juliano
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 3.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 4.  How far can virtual screening take us in drug discovery?

Authors:  Supratik Kar; Kunal Roy
Journal:  Expert Opin Drug Discov       Date:  2013-01-21       Impact factor: 6.098

5.  Strategic siRNA screening approaches to target cancer at the Cancer Research UK Beatson Institute.

Authors:  Emma J Shanks
Journal:  Comb Chem High Throughput Screen       Date:  2014-05       Impact factor: 1.339

6.  The Sheffield RNAi Screening Facility (SRSF): portfolio growth and technology development.

Authors:  Stephen Brown
Journal:  Comb Chem High Throughput Screen       Date:  2014-05       Impact factor: 1.339
  6 in total
  5 in total

Review 1.  Redox Systems Biology: Harnessing the Sentinels of the Cysteine Redoxome.

Authors:  Jason M Held
Journal:  Antioxid Redox Signal       Date:  2019-09-09       Impact factor: 8.401

2.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

Review 3.  The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.

Authors:  Anna Karawajczyk; Kristina M Orrling; Jon S B de Vlieger; Ton Rijnders; Dimitrios Tzalis
Journal:  Front Med (Lausanne)       Date:  2017-01-19

Review 4.  Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: lessons from the pandemic and preparing for future health crises.

Authors:  Natesh Singh; Bruno O Villoutreix
Journal:  Comput Struct Biotechnol J       Date:  2021-04-26       Impact factor: 7.271

5.  HighVia-A Flexible Live-Cell High-Content Screening Pipeline to Assess Cellular Toxicity.

Authors:  Alison Howarth; Martin Schröder; Raquel C Montenegro; David H Drewry; Heba Sailem; Val Millar; Susanne Müller; Daniel V Ebner
Journal:  SLAS Discov       Date:  2020-05-27       Impact factor: 3.341
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.